4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company: Nautilus Biotechnology, Inc.
Filed: June 3, 2021
Period of Report: June 3, 2021
Accession Number: 0001062993-21-005377

View Document ↗ View on SEC.gov ↗